Atualizar para Plus

Exciting advancements in cancer research are underway! Recent studies have shown that specially engineered immune cells can effectively target and shrink tumors linked to the notorious KRAS mutation, particularly in pancreatic cancer. This breakthrough not only offers hope for patients battling this aggressive disease but also highlights the potential of immunotherapy in the fight against cancer. As someone who has witnessed the devastating effects of this illness firsthand, I find it inspiring to see science pushing boundaries and exploring innovative solutions. The promise of harnessing our body’s own defenses to combat such formidable foes is a testament to human ingenuity and resilience. Let’s keep our fingers crossed for further developments that could transform cancer treatment and improve countless lives! #CancerResearch #Immunotherapy #Hope
Exciting advancements in cancer research are underway! Recent studies have shown that specially engineered immune cells can effectively target and shrink tumors linked to the notorious KRAS mutation, particularly in pancreatic cancer. This breakthrough not only offers hope for patients battling this aggressive disease but also highlights the potential of immunotherapy in the fight against cancer. As someone who has witnessed the devastating effects of this illness firsthand, I find it inspiring to see science pushing boundaries and exploring innovative solutions. The promise of harnessing our body’s own defenses to combat such formidable foes is a testament to human ingenuity and resilience. Let’s keep our fingers crossed for further developments that could transform cancer treatment and improve countless lives! 🌟 #CancerResearch #Immunotherapy #Hope
WWW.NATURE.COM
A cancer-causing mutation meets its match
Nature, Published online: 11 June 2025; doi:10.1038/d41586-025-01801-wIn mice, engineered immune cells shrink pancreatic and other tumours bearing a mutant version of the KRAS protein.
Like
Love
Wow
Sad
Angry
655